Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Valkyrie Clinical Trials, Los Angeles, California Rocky Mountain Cancer Centers, Lone Tree, Colorado Carle Cancer Institute, Urbana, Illinois Markey Cancer Center, Lexington, Kentucky Maryland Oncology Hematology, Rockville, Maryland The Valley Hospital - Luckow Pavilion, Paramus, New Jersey Gabrail Cancer Center Research, Canton, Ohio Millennium Oncology, Houston, Texas Virginia Cancer Specialists, Fairfax, Virginia Virginia Oncology Associates, Norfolk, Virginia